Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2010
07/13/2010USRE41439 Pharmaceutical compositions and methods for use
07/13/2010US7754882 such as Cis-6-Phenyl-9-(3-piperidin-1-yl-propoxy)-1,2,3,5,6,10b-hexahydro-pyrrolo [2,1a]isoquinoline, used as histamine H3 receptor and serotonin transporter modulators useful in the treatment of depression
07/13/2010US7754881 prevents the aggregation of the carbon nanotubes; nanotubes can be formed into a thin film having uniform properties throughout
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders
07/13/2010US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
07/13/2010US7754713 such as 6-(4-Hydroxy-3,5-dimethylphenyl)-4-(7-methyl-1H-benzimidazol-2-yl)-2H-pyridazin-3-one, used as cyclin-dependent kinase inhibitors, for the treatment of cancer, in particular solid tumors or leukemia; anticarcinogenic agents
07/13/2010US7754712 11-(4-Chloro-benzenesulfonyl)-4,5,11-triaza-tricyclo[6.2.1.02,6]undeca-2(6),3-diene; inhibit beta-amyloid peptide release or its synthesis; secretases inhibitor; neurodegenerative and neurological diseases: Alzheimer's, Parkinson's diseases, Down's syndrome, degenerative dementias
07/13/2010US7754348 Phenanthroline compound and organic light emitting device using the same
07/13/2010US7754189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
07/13/2010CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands
07/13/2010CA2457451C Naphthyridine derivatives
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2427837C Radioactive member for use in brachytherapy and method of making
07/13/2010CA2352066C Process for the preparation of derivatized polymers
07/08/2010WO2010078427A1 Substituted pyrazolo [3, 4-b] pyridine compounds
07/08/2010WO2010078421A1 Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
07/08/2010WO2010078408A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010WO2010078307A1 Spiro-oxindole-derivatives as sodium channel blockers
07/08/2010WO2010078294A1 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010077530A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
07/08/2010WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010WO2010075760A1 Heterocyclic nitrogenous compounds with insecticidal activity, their preparation methods and uses thereof
07/08/2010WO2010056633A3 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
07/08/2010WO2010015518A3 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
07/08/2010US20100174084 2-Alkoxy-6-alkyl-phenyl-substituted Spirocyclic Tetramic Acid Derivatives
07/08/2010US20100173933 Antibacterial agents
07/08/2010US20100173932 Sub-type selective amides of diazabicycloalkanes
07/08/2010US20100173930 Certain Chemical Entities, Compositions and Methods
07/08/2010US20100173929 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof
07/08/2010US20100173923 4 (pyrrolopyridinyl)pyrimidinyl-2-amine derivatives
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173913 Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents
07/08/2010US20100173911 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES
07/08/2010US20100173906 Substituted 3,4,6,7-Tetrahydro-5H-1,2a,4a,8-Tetraazacyclopenta[cd]Phenalenes and Methods
07/08/2010US20100173898 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
07/08/2010US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/08/2010US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
07/08/2010US20100173824 Azepinoindole Derivatives As Pharmaceutical Agents
07/08/2010US20100173823 Alpha2c adrenoreceptor agonists
07/08/2010US20100173134 Film and Device Using Layer Based on Ribtan Material
07/08/2010US20100171108 Use of n,n'-bis(1,1-dihydroperfluoro-c3-c5-alkyl)-perylene-3,4:9,10- tetracarboxylic diimides
07/08/2010CA2748491A1 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
07/08/2010CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010CA2748276A1 Substituted pyrazolo [3, 4-b] pyridine compounds
07/08/2010CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010CA2748066A1 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010CA2745071A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
07/07/2010EP2204369A1 Process for preparing varenicline and intermediates for use therein
07/07/2010EP2204365A1 Alkylsulfone derivative
07/07/2010EP2203450A2 Chiral synthesis of diazepinoquinolines
07/07/2010EP2203449A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
07/07/2010EP2203442A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
07/07/2010EP2203051A1 Octahydropentalene compounds as chemokine receptor antagonists
07/07/2010EP1765829B1 Tricyclic compounds and their use as mglur1 antagonists
07/07/2010EP1611133B1 Condensed n-heterocyclic compound and use thereoff as crf receptor antagonist
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN1942469B Condensed pyridine derivatives useful as A28 adenosine receptor antagonists
07/07/2010CN101772499A Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
07/07/2010CN101772498A Heteroaryl amide analogues as p2x7 antagonists
07/07/2010CN101772493A gamma secretase modulators
07/07/2010CN101768161A Nitrogen-containing heterocyclic compound with pesticidal activity, preparation and application thereof
07/06/2010US7750556 Triazole derivatives and use thereof in organic light-emitting diodes (OLEDs)
07/06/2010US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds
07/06/2010US7750159 Phenanthroline derivative and light emitting element and light emitting device using the same
07/06/2010US7750151 Inhibitors of Akt activity
07/06/2010US7750017 Anticancer agents; hyperproliferative diseases; 4-(phenylamino)benzothieno[2,3-d]pyrimidines; inhibit the tyrosine kinase activities of EGFR (erbB1) and HER2
07/06/2010US7750016 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
07/06/2010CA2539814C Isoquinolinone potassium channel inhibitors
07/01/2010WO2010075380A1 Anti-viral compounds
07/01/2010WO2010075376A2 Anti-viral compounds
07/01/2010WO2010075273A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
07/01/2010WO2010075269A1 Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
07/01/2010WO2010075068A1 Pyridopyrimidine derivatives and methods of use thereof
07/01/2010WO2010074586A1 Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
07/01/2010WO2010074244A1 Isoquinoline derivative
07/01/2010WO2010074193A1 Novel bicyclic heterocyclic compound
07/01/2010WO2010073719A1 Eg5 inhibitor
07/01/2010WO2010072823A1 PYRAZOLE[1,5a]PYRIDINE DERIVATIVES
07/01/2010WO2010072722A1 Piperidine derivatives useful as orexin antagonists
07/01/2010WO2010072610A1 One-step process for preparing paliperidone and its oxalate salt
07/01/2010WO2010072399A1 7-azaindirubins, 7'azaindirubins, 7,7'-diazaindirubins and the corresponding 3'-oxime ether derivatives thereof, their production and use as a medicament
07/01/2010WO2010072352A1 1, 2, 4 -oxadiazole derivatives and their therapeutic use
07/01/2010WO2010049500A3 A process for the preparation of tadalafil
07/01/2010WO2010033980A3 4-azaindole bisphosphonates
07/01/2010WO2010033978A3 IMIDAZO[1,2-α ]PYRIDINYL BISPHOSPHONATES
07/01/2010WO2010005876A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/01/2010US20100168430 Multikinase inhibitor
07/01/2010US20100168429 Transition metal catalyzed synthesis of N-aminoindoles
07/01/2010US20100168417 2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use in the Treatment for Cancer
07/01/2010US20100168159 Hetero compound
07/01/2010US20100168153 Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
07/01/2010US20100168150 Camptothecin Analogue Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them.
07/01/2010US20100168149 Camptothecin Analogue Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them